The global market for Ondansetron Hydrochloride for Injection was valued at US$ 392 million in the year 2024 and is projected to reach a revised size of US$ 460 million by 2031, growing at a CAGR of 2.2% during the forecast period.

Ondansetron Hydrochloride for Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ondansetron Hydrochloride for Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Ondansetron hydrochloride for injection is a sterile, non‑pyrogenic 5‑HT3receptor antagonist used to prevent nausea and vomiting associated with chemotherapy, radiation therapy, and surgery. The solution is clear and colorless at a concentration of 2 mg/mL and can be administered intravenously or intramuscularly. The recommended adult dose is 0.15 mg/kg IV over 15 minutes (maximum 16 mg per dose), with additional doses as clinically indicated. Common adverse reactions include headache, constipation, fever, and injection site irritation; rare but serious effects include QT interval prolongation, arrhythmias, hypersensitivity, and serotonin syndrome .

North American market for Ondansetron Hydrochloride for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Ondansetron Hydrochloride for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Ondansetron Hydrochloride for Injection include Fresenius, Novartis, Intas Pharmaceuticals, Hikma Pharmaceuticals, Laboratorios Normon, Maruishi Pharmaceutical, Viatris, Qilu Pharmaceutical, Fuan Pharmaceutical, Beijing Sciecure Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ondansetron Hydrochloride for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ondansetron Hydrochloride for Injection.

The Ondansetron Hydrochloride for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ondansetron Hydrochloride for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ondansetron Hydrochloride for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ondansetron Hydrochloride for Injection Market Report

Report Metric	Details
Report Name	Ondansetron Hydrochloride for Injection Market
Accounted market size in year	US$ 392 million
Forecasted market size in 2031	US$ 460 million
CAGR	2.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	2ml 4ml Other
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fresenius, Novartis, Intas Pharmaceuticals, Hikma Pharmaceuticals, Laboratorios Normon, Maruishi Pharmaceutical, Viatris, Qilu Pharmaceutical, Fuan Pharmaceutical, Beijing Sciecure Pharmaceutical, Harbin Medisan Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ondansetron Hydrochloride for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Ondansetron Hydrochloride for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Ondansetron Hydrochloride for Injection Market growing?

Ans: The Ondansetron Hydrochloride for Injection Market witnessing a CAGR of 2.2% during the forecast period 2025-2031.

What is the Ondansetron Hydrochloride for Injection Market size in 2031?

Ans: The Ondansetron Hydrochloride for Injection Market size in 2031 will be US$ 460 million.

Who are the main players in the Ondansetron Hydrochloride for Injection Market report?

Ans: The main players in the Ondansetron Hydrochloride for Injection Market are Fresenius, Novartis, Intas Pharmaceuticals, Hikma Pharmaceuticals, Laboratorios Normon, Maruishi Pharmaceutical, Viatris, Qilu Pharmaceutical, Fuan Pharmaceutical, Beijing Sciecure Pharmaceutical, Harbin Medisan Pharmaceutical

What are the Application segmentation covered in the Ondansetron Hydrochloride for Injection Market report?

Ans: The Applications covered in the Ondansetron Hydrochloride for Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Ondansetron Hydrochloride for Injection Market report?

Ans: The Types covered in the Ondansetron Hydrochloride for Injection Market report are 2ml, 4ml, Other

1 Ondansetron Hydrochloride for Injection Market Overview

1.1 Product Definition

1.2 Ondansetron Hydrochloride for Injection by Type

1.2.1 Global Ondansetron Hydrochloride for Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 2ml

1.2.3 4ml

1.2.4 Other

1.3 Ondansetron Hydrochloride for Injection by Application

1.3.1 Global Ondansetron Hydrochloride for Injection Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Ondansetron Hydrochloride for Injection Market Size Estimates and Forecasts

1.4.1 Global Ondansetron Hydrochloride for Injection Revenue 2020-2031

1.4.2 Global Ondansetron Hydrochloride for Injection Sales 2020-2031

1.4.3 Global Ondansetron Hydrochloride for Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Ondansetron Hydrochloride for Injection Market Competition by Manufacturers

2.1 Global Ondansetron Hydrochloride for Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Ondansetron Hydrochloride for Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Ondansetron Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Product Type & Application

2.7 Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Date of Enter into This Industry

2.8 Global Ondansetron Hydrochloride for Injection Market Competitive Situation and Trends

2.8.1 Global Ondansetron Hydrochloride for Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Ondansetron Hydrochloride for Injection Players Market Share by Revenue

2.8.3 Global Ondansetron Hydrochloride for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Ondansetron Hydrochloride for Injection Market Scenario by Region

3.1 Global Ondansetron Hydrochloride for Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Ondansetron Hydrochloride for Injection Sales by Region: 2020-2031

3.2.1 Global Ondansetron Hydrochloride for Injection Sales by Region: 2020-2025

3.2.2 Global Ondansetron Hydrochloride for Injection Sales by Region: 2026-2031

3.3 Global Ondansetron Hydrochloride for Injection Revenue by Region: 2020-2031

3.3.1 Global Ondansetron Hydrochloride for Injection Revenue by Region: 2020-2025

3.3.2 Global Ondansetron Hydrochloride for Injection Revenue by Region: 2026-2031

3.4 North America Ondansetron Hydrochloride for Injection Market Facts & Figures by Country

3.4.1 North America Ondansetron Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Ondansetron Hydrochloride for Injection Sales by Country (2020-2031)

3.4.3 North America Ondansetron Hydrochloride for Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Ondansetron Hydrochloride for Injection Market Facts & Figures by Country

3.5.1 Europe Ondansetron Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Ondansetron Hydrochloride for Injection Sales by Country (2020-2031)

3.5.3 Europe Ondansetron Hydrochloride for Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Ondansetron Hydrochloride for Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Ondansetron Hydrochloride for Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Ondansetron Hydrochloride for Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Ondansetron Hydrochloride for Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Ondansetron Hydrochloride for Injection Market Facts & Figures by Country

3.7.1 Latin America Ondansetron Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Ondansetron Hydrochloride for Injection Sales by Country (2020-2031)

3.7.3 Latin America Ondansetron Hydrochloride for Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Ondansetron Hydrochloride for Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Ondansetron Hydrochloride for Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Ondansetron Hydrochloride for Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Ondansetron Hydrochloride for Injection Sales by Type (2020-2031)

4.1.1 Global Ondansetron Hydrochloride for Injection Sales by Type (2020-2025)

4.1.2 Global Ondansetron Hydrochloride for Injection Sales by Type (2026-2031)

4.1.3 Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2020-2031)

4.2 Global Ondansetron Hydrochloride for Injection Revenue by Type (2020-2031)

4.2.1 Global Ondansetron Hydrochloride for Injection Revenue by Type (2020-2025)

4.2.2 Global Ondansetron Hydrochloride for Injection Revenue by Type (2026-2031)

4.2.3 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2020-2031)

4.3 Global Ondansetron Hydrochloride for Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Ondansetron Hydrochloride for Injection Sales by Application (2020-2031)

5.1.1 Global Ondansetron Hydrochloride for Injection Sales by Application (2020-2025)

5.1.2 Global Ondansetron Hydrochloride for Injection Sales by Application (2026-2031)

5.1.3 Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2020-2031)

5.2 Global Ondansetron Hydrochloride for Injection Revenue by Application (2020-2031)

5.2.1 Global Ondansetron Hydrochloride for Injection Revenue by Application (2020-2025)

5.2.2 Global Ondansetron Hydrochloride for Injection Revenue by Application (2026-2031)

5.2.3 Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2020-2031)

5.3 Global Ondansetron Hydrochloride for Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Fresenius

6.1.1 Fresenius Company Information

6.1.2 Fresenius Description and Business Overview

6.1.3 Fresenius Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Fresenius Ondansetron Hydrochloride for Injection Product Portfolio

6.1.5 Fresenius Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Company Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis Ondansetron Hydrochloride for Injection Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Intas Pharmaceuticals

6.3.1 Intas Pharmaceuticals Company Information

6.3.2 Intas Pharmaceuticals Description and Business Overview

6.3.3 Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio

6.3.5 Intas Pharmaceuticals Recent Developments/Updates

6.4 Hikma Pharmaceuticals

6.4.1 Hikma Pharmaceuticals Company Information

6.4.2 Hikma Pharmaceuticals Description and Business Overview

6.4.3 Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Product Portfolio

6.4.5 Hikma Pharmaceuticals Recent Developments/Updates

6.5 Laboratorios Normon

6.5.1 Laboratorios Normon Company Information

6.5.2 Laboratorios Normon Description and Business Overview

6.5.3 Laboratorios Normon Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Laboratorios Normon Ondansetron Hydrochloride for Injection Product Portfolio

6.5.5 Laboratorios Normon Recent Developments/Updates

6.6 Maruishi Pharmaceutical

6.6.1 Maruishi Pharmaceutical Company Information

6.6.2 Maruishi Pharmaceutical Description and Business Overview

6.6.3 Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio

6.6.5 Maruishi Pharmaceutical Recent Developments/Updates

6.7 Viatris

6.7.1 Viatris Company Information

6.7.2 Viatris Description and Business Overview

6.7.3 Viatris Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Viatris Ondansetron Hydrochloride for Injection Product Portfolio

6.7.5 Viatris Recent Developments/Updates

6.8 Qilu Pharmaceutical

6.8.1 Qilu Pharmaceutical Company Information

6.8.2 Qilu Pharmaceutical Description and Business Overview

6.8.3 Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio

6.8.5 Qilu Pharmaceutical Recent Developments/Updates

6.9 Fuan Pharmaceutical

6.9.1 Fuan Pharmaceutical Company Information

6.9.2 Fuan Pharmaceutical Description and Business Overview

6.9.3 Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio

6.9.5 Fuan Pharmaceutical Recent Developments/Updates

6.10 Beijing Sciecure Pharmaceutical

6.10.1 Beijing Sciecure Pharmaceutical Company Information

6.10.2 Beijing Sciecure Pharmaceutical Description and Business Overview

6.10.3 Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio

6.10.5 Beijing Sciecure Pharmaceutical Recent Developments/Updates

6.11 Harbin Medisan Pharmaceutical

6.11.1 Harbin Medisan Pharmaceutical Company Information

6.11.2 Harbin Medisan Pharmaceutical Description and Business Overview

6.11.3 Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Product Portfolio

6.11.5 Harbin Medisan Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Ondansetron Hydrochloride for Injection Industry Chain Analysis

7.2 Ondansetron Hydrochloride for Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Ondansetron Hydrochloride for Injection Production Mode & Process Analysis

7.4 Ondansetron Hydrochloride for Injection Sales and Marketing

7.4.1 Ondansetron Hydrochloride for Injection Sales Channels

7.4.2 Ondansetron Hydrochloride for Injection Distributors

7.5 Ondansetron Hydrochloride for Injection Customer Analysis

8 Ondansetron Hydrochloride for Injection Market Dynamics

8.1 Ondansetron Hydrochloride for Injection Industry Trends

8.2 Ondansetron Hydrochloride for Injection Market Drivers

8.3 Ondansetron Hydrochloride for Injection Market Challenges

8.4 Ondansetron Hydrochloride for Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fresenius

Novartis

Intas Pharmaceuticals

Hikma Pharmaceuticals

Laboratorios Normon

Maruishi Pharmaceutical

Viatris

Qilu Pharmaceutical

Fuan Pharmaceutical

Beijing Sciecure Pharmaceutical

Harbin Medisan Pharmaceutical

List of Tables

Table 1. Global Ondansetron Hydrochloride for Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Ondansetron Hydrochloride for Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Ondansetron Hydrochloride for Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Ondansetron Hydrochloride for Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Ondansetron Hydrochloride for Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Ondansetron Hydrochloride for Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Ondansetron Hydrochloride for Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Ondansetron Hydrochloride for Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Ondansetron Hydrochloride for Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Product Type & Application

Table 12. Global Key Manufacturers of Ondansetron Hydrochloride for Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Ondansetron Hydrochloride for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ondansetron Hydrochloride for Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Ondansetron Hydrochloride for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Ondansetron Hydrochloride for Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Ondansetron Hydrochloride for Injection Sales Market Share by Region (2020-2025)

Table 19. Global Ondansetron Hydrochloride for Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Ondansetron Hydrochloride for Injection Sales Market Share by Region (2026-2031)

Table 21. Global Ondansetron Hydrochloride for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Ondansetron Hydrochloride for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Ondansetron Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Ondansetron Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Ondansetron Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Ondansetron Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Ondansetron Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Ondansetron Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Ondansetron Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Ondansetron Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Ondansetron Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Ondansetron Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Ondansetron Hydrochloride for Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Ondansetron Hydrochloride for Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Ondansetron Hydrochloride for Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Ondansetron Hydrochloride for Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Ondansetron Hydrochloride for Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ondansetron Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Ondansetron Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Ondansetron Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Ondansetron Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Ondansetron Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Ondansetron Hydrochloride for Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Ondansetron Hydrochloride for Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Ondansetron Hydrochloride for Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Ondansetron Hydrochloride for Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Ondansetron Hydrochloride for Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Ondansetron Hydrochloride for Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2020-2025)

Table 53. Global Ondansetron Hydrochloride for Injection Sales Market Share by Type (2026-2031)

Table 54. Global Ondansetron Hydrochloride for Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Ondansetron Hydrochloride for Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Ondansetron Hydrochloride for Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Ondansetron Hydrochloride for Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2020-2025)

Table 63. Global Ondansetron Hydrochloride for Injection Sales Market Share by Application (2026-2031)

Table 64. Global Ondansetron Hydrochloride for Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Ondansetron Hydrochloride for Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Ondansetron Hydrochloride for Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Application (2026-2031)

Table 70. Fresenius Company Information

Table 71. Fresenius Description and Business Overview

Table 72. Fresenius Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Fresenius Ondansetron Hydrochloride for Injection Product

Table 74. Fresenius Recent Developments/Updates

Table 75. Novartis Company Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Novartis Ondansetron Hydrochloride for Injection Product

Table 79. Novartis Recent Developments/Updates

Table 80. Intas Pharmaceuticals Company Information

Table 81. Intas Pharmaceuticals Description and Business Overview

Table 82. Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Intas Pharmaceuticals Ondansetron Hydrochloride for Injection Product

Table 84. Intas Pharmaceuticals Recent Developments/Updates

Table 85. Hikma Pharmaceuticals Company Information

Table 86. Hikma Pharmaceuticals Description and Business Overview

Table 87. Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hikma Pharmaceuticals Ondansetron Hydrochloride for Injection Product

Table 89. Hikma Pharmaceuticals Recent Developments/Updates

Table 90. Laboratorios Normon Company Information

Table 91. Laboratorios Normon Description and Business Overview

Table 92. Laboratorios Normon Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Laboratorios Normon Ondansetron Hydrochloride for Injection Product

Table 94. Laboratorios Normon Recent Developments/Updates

Table 95. Maruishi Pharmaceutical Company Information

Table 96. Maruishi Pharmaceutical Description and Business Overview

Table 97. Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Maruishi Pharmaceutical Ondansetron Hydrochloride for Injection Product

Table 99. Maruishi Pharmaceutical Recent Developments/Updates

Table 100. Viatris Company Information

Table 101. Viatris Description and Business Overview

Table 102. Viatris Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Viatris Ondansetron Hydrochloride for Injection Product

Table 104. Viatris Recent Developments/Updates

Table 105. Qilu Pharmaceutical Company Information

Table 106. Qilu Pharmaceutical Description and Business Overview

Table 107. Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Qilu Pharmaceutical Ondansetron Hydrochloride for Injection Product

Table 109. Qilu Pharmaceutical Recent Developments/Updates

Table 110. Fuan Pharmaceutical Company Information

Table 111. Fuan Pharmaceutical Description and Business Overview

Table 112. Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Fuan Pharmaceutical Ondansetron Hydrochloride for Injection Product

Table 114. Fuan Pharmaceutical Recent Developments/Updates

Table 115. Beijing Sciecure Pharmaceutical Company Information

Table 116. Beijing Sciecure Pharmaceutical Description and Business Overview

Table 117. Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Beijing Sciecure Pharmaceutical Ondansetron Hydrochloride for Injection Product

Table 119. Beijing Sciecure Pharmaceutical Recent Developments/Updates

Table 120. Harbin Medisan Pharmaceutical Company Information

Table 121. Harbin Medisan Pharmaceutical Description and Business Overview

Table 122. Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Harbin Medisan Pharmaceutical Ondansetron Hydrochloride for Injection Product

Table 124. Harbin Medisan Pharmaceutical Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Ondansetron Hydrochloride for Injection Distributors List

Table 128. Ondansetron Hydrochloride for Injection Customers List

Table 129. Ondansetron Hydrochloride for Injection Market Trends

Table 130. Ondansetron Hydrochloride for Injection Market Drivers

Table 131. Ondansetron Hydrochloride for Injection Market Challenges

Table 132. Ondansetron Hydrochloride for Injection Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Ondansetron Hydrochloride for Injection

Figure 2. Global Ondansetron Hydrochloride for Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ondansetron Hydrochloride for Injection Market Share by Type: 2024 & 2031

Figure 4. 2ml Product Picture

Figure 5. 4ml Product Picture

Figure 6. Other Product Picture

Figure 7. Global Ondansetron Hydrochloride for Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Ondansetron Hydrochloride for Injection Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Others

Figure 12. Global Ondansetron Hydrochloride for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Ondansetron Hydrochloride for Injection Market Size (2020-2031) & (US$ Million)

Figure 14. Global Ondansetron Hydrochloride for Injection Sales (2020-2031) & (K Units)

Figure 15. Global Ondansetron Hydrochloride for Injection Average Price (US$/Unit) & (2020-2031)

Figure 16. Ondansetron Hydrochloride for Injection Report Years Considered

Figure 17. Ondansetron Hydrochloride for Injection Sales Share by Manufacturers in 2024

Figure 18. Global Ondansetron Hydrochloride for Injection Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Ondansetron Hydrochloride for Injection Players: Market Share by Revenue in Ondansetron Hydrochloride for Injection in 2024

Figure 20. Ondansetron Hydrochloride for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Ondansetron Hydrochloride for Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Ondansetron Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 23. North America Ondansetron Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 24. United States Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Ondansetron Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 27. Europe Ondansetron Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 28. Germany Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Ondansetron Hydrochloride for Injection Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Ondansetron Hydrochloride for Injection Revenue Market Share by Region (2020-2031)

Figure 35. China Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Ondansetron Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 43. Latin America Ondansetron Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Ondansetron Hydrochloride for Injection Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Ondansetron Hydrochloride for Injection Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Ondansetron Hydrochloride for Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Ondansetron Hydrochloride for Injection by Type (2020-2031)

Figure 54. Global Revenue Market Share of Ondansetron Hydrochloride for Injection by Type (2020-2031)

Figure 55. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Ondansetron Hydrochloride for Injection by Application (2020-2031)

Figure 57. Global Revenue Market Share of Ondansetron Hydrochloride for Injection by Application (2020-2031)

Figure 58. Global Ondansetron Hydrochloride for Injection Price (US$/Unit) by Application (2020-2031)

Figure 59. Ondansetron Hydrochloride for Injection Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Ondansetron Hydrochloride for Injection Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-11Q19732

Global Ondansetron Hydrochloride for Injection Market Research Report 2025

FEATURED COMPANIES

Ondansetron Hydrochloride for Injection Market Size

Ondansetron Hydrochloride for Injection Market

Report Scope

Scope of Ondansetron Hydrochloride for Injection Market Report

Core Chapters

FAQ for this report

How fast is Ondansetron Hydrochloride for Injection Market growing?

What is the Ondansetron Hydrochloride for Injection Market size in 2031?

Who are the main players in the Ondansetron Hydrochloride for Injection Market report?

What are the Application segmentation covered in the Ondansetron Hydrochloride for Injection Market report?

What are the Type segmentation covered in the Ondansetron Hydrochloride for Injection Market report?

FEATURED COMPANIES

On board Charger

Single User, Electronic (PDF)